348

Mieczysław Wender. “Prevalence of Helicobacter pylori Infection Among Patients with Multiple Sclerosis”. Neurologia i neurochirurgia polska 37, № 1 (2003); Wei Li et al. “Helicobacter pylori Infection Is a Potential Protective Factor Against Conventional Multiple Sclerosis in the Japanese Population”. Journal of Neuroimmunology 184, nos. 1–2 (2007); Amr H. Sawalha et al. “Association between Systemic Lupus Erythematosus and Helicobacter pylori Seronegativity”. Journal of Rheumatology 31, № 8 (2004); Yoshihiro Matsukawa et al. “Exacerbation of Rheumatoid Arthritis Following Helicobacter pylori Eradication: Disruption of Established Oral Tolerance Against Heat Shock Protein?” Medical Hypotheses 64, № 1 (2005); Ai Tada et al. “Eradication of Helicobacter pylori May Trigger Onset of Type 1 Diabetes: A Case Report”. Annals of the New York Academy of Sciences 1150 (2008); Antonio Tursi. “Onset of Crohn’s Disease After Helicobacter pylori Eradication”. Inflammatory Bowel Diseases 12, № 10 (2006); W. Li et al. “Association of Anti-Helicobacter pylori Neutrophil-activating Protein Antibody Response with Anti-aquaporin-4 Autoimmunity in Japanese Patients with Multiple Sclerosis and Neuromyelitis Optica”. Multiple Sclerosis 15, № 12 (2009).